King Salman of Saudi Arabia is currently undergoing medical tests to address concerns of lung inflammation. This situation highlights important health considerations and potential impacts on the kingdom's governance. Observers are closely monitoring the developments for any future implications in leadership and stability within the region.
RIYADH, Saudi Arabia - Saudi King Salman will undergo medical tests for lung inflammation on Sunday evening, according to a statement from the royal court released by the state news agency.
The 88-year-old King, who rules the world's largest oil exporter and a key US ally in the Middle East, has previously received medical treatment for lung inflammation in May. This latest test follows a royal decree issued by the King in August, authorizing the cabinet to convene in his absence, as well as that of the Crown Prince.
The decree stipulates that in the absence of both the King and Crown Prince, the oldest member of the cabinet who is a descendant of King Abdulaziz Al Saud, the founder of the Saudi state, will chair the meeting.
The King last chaired a cabinet meeting in August. No further details about the medical tests have been revealed by the royal court.
